Category: Pharmaceuticals
As a part of an expanded collaboration, GeoVax Labs Inc., an American biotechnology company and Leidos Inc., a scientific research company, have reportedly announced the development of malaria vaccine candidates. The USAID (United States Agency for International Development) MVDP (Malaria Vaccine Development Program) is reported …
With the Fast Track designation, Iovance is likely to increase the frequency of its communication with the U.S. FDA. Reputed biotechnology company Iovance Biotherapeutics, Inc., has reportedly been granted the Fast Track designation for its adoptive cell therapy LN-145, developed using its proprietary TIL manufacturing …
In a recent turn of events, Bausch + Lomb, an eye health behemoth and a fully owned business unit of Bausch Health Companies Incorporation, has reportedly declared that the United States Food and Drug Administration has given approval to LOTEMAX® SM 0.38 percent, a novel …
In a recent turn of events, biopharmaceutical giant AstraZeneca’s Brilinta has reportedly cleared its phase 3 patient trial called Themis. According to sources familiar with the development, Brillinta when consumed in conjunction with aspirin reduces the combined risk of stroke, heart attack, and cardiovascular death …
The latest move underlines MediPharm’s first international export deal. AusCann Group Holdings Ltd. (AC8), an Australian cannabis medicine company, has reportedly entered into a supply agreement with the leading cannabis extractor in Canada, MediPharm Labs Corp., for the purchase of cannabis resin. AusCann, for the …
The study specifies the possibility of preventing or delaying kidney failure and the need for dialysis or a kidney transplant in patients with rare chronic kidney disease. U.S. clinical-stage biopharmaceutical firm, Reata Pharmaceuticals, Inc. has recently announced its final, positive result from the focal segmental …
The FDA will decide on the definitive approval by the 19th of August 2019. The U.S. Food & Drug Administration (FDA) has reportedly accepted the BLA (Biologics License Application) submitted by the Swiss multinational healthcare company, Roche. The company has been officially granted Priority Review …
Glenmark Pharmaceuticals, the Mumbai-headquartered pharmaceutical company, has made it to the front page for receiving the USFDA (United States Food & Drug Administration) nod for its generic version of skin inflammation treatment foam, Olux foam 0.05 per cent of Mylan Pharmaceuticals. As per IQVIA sales …
Shenzhen Chipscreen Biosciences Ltd., a leading China-based integrated biotech company, has reportedly entered into a collaboration agreement with Innovent Biologics Inc., a Chinese development-stage biopharmaceutical company, in a major effort to evaluate the tolerability and safety of the combination therapy involving Innovent’s Sintilimab and Chipscreen’s …
